New trial shows immunotherapy post-surgery improves overall survival for kidney cancer

1 year ago 30

For the first time in fifty years, results from a Phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

1. Homepage
2. category-label-
3. New trial shows immunotherapy post-surgery improves overall survival for kidney cancer